Work

Histopathological Assessment of Liver and Spleen Following Intracortical AAV9–NeuroD1 Administration in a Non-Human Primate Model of Ischaemic Stroke

Year: 2026
Type: dissertation
Abstract: Intracortical delivery of adeno-associated virus serotype 9 (AAV9) encoding neurogenic differentiation factor 1 (NeuroD1) is being investigated as a regenerative strategy for structurally injured cortex. Although focal administration is intended to concentrate vector exposure within the central nervous system, the chronic peripheral tissue consequences of this approach remain incompletely characterised. This thesis evaluated hepatic and splenic outcomes approximately eight months after stereotactic intracortical AAV9–NeuroD1 administration in rhesus (Macaca mulatta) and cynomolgus (Macaca fascicularis) macaques subjected to middle cerebral artery occlusion. Vector was administered 14 days after ischaemic injury. At necropsy, liver and spleen were assessed for chronic structural injury by haematoxylin and eosin histopathology; splenic white:red pulp representation was quantified morphometrically; and hepatic CD163- and CD169-associated macrophage phenotypes were characterised by multiplex immunofluorescence. Comparisons included reporter-vector control, low-dose AAV9–NeuroD1, and high-dose AAV9–NeuroD1 conditions. Hepatic lobular organisation and splenic white- and red-pulp architecture were preserved across groups, without a pattern of persistent destructive pathology at the terminal endpoint. Splenic white:red pulp ratios varied descriptively, with approximate group means of 2.5, 1.8, and 8.0 in control, low-dose, and high-dose animals, respectively. Hepatic CD163-positive frequencies were closely similar across groups, whereas CD169-positive representation was descriptively greatest in the low-dose group. Animal-nested mixed-effects models estimated treatment effects of F(2,5.651) = 0.735, p = 0.521 for CD163 and F(2,5.077) = 1.666, p = 0.278 for CD169. An archived CD163/CD169 co-expression output was lowest in the high-dose group but is most plausibly interpreted as a differently normalised overlap/co-expression metric rather than a DAPI-normalised double-positive cell frequency. Collectively, the findings define a chronic peripheral phenotype characterised by preserved organ architecture with heterogeneous splenic and hepatic immune-associated patterns. The study does not establish peripheral vector biodistribution or productive NeuroD1 expression; direct vector-genome, transgene-expression, longitudinal immune, and clinical-chemistry measurements are required to connect these tissue phenotypes to peripheral exposure and mechanism.
Institution: Queen's University
Language: English
Subfield: Genetics
Open Access status: green
OpenAlex ID: W7221402766
Cites: 92
Cited by:
Related to: 10